Study to Assess Adverse Events and Change in Disease State of Oral Venetoclax in Combination With Subcutaneous (SC) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Chemotherapy in China
Clinical trial NCT05144243 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05144243
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-06
- Primary completion
- 2026-03-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.